Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type 1 selected

Type

Guidance programme

HealthTech approach

HealthTech approach

Area of interest

Showing 576 to 600 of 2047

TitleReference numberPublishedLast updated
Prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasiaHTG639
Removal, preservation and subsequent reimplantation of ovarian tissue to prevent symptoms from the menopauseHTG640
Avacopan for treating severe active granulomatosis with polyangiitis or microscopic polyangiitisTA825
Vedolizumab for treating chronic refractory pouchitis after surgery for ulcerative colitis (terminated appraisal)TA826
Colorectal cancer prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomasCG118
Melphalan for haematological diseases before allogeneic haematopoietic stem cell transplant (terminated appraisal)TA822
Dexamethasone intravitreal implant for treating diabetic macular oedemaTA824
Self-harm: assessment, management and preventing recurrenceNG225
Faecal microbiota transplant for recurrent Clostridioides difficile infectionHTG638
Brolucizumab for treating diabetic macular oedemaTA820
iFuse for treating chronic sacroiliac joint painHTG488
Focal resurfacing implants to treat articular cartilage damage in the kneeHTG635
Transcutaneous electrical neuromuscular stimulation for urinary incontinenceHTG636
Superficial venous arterialisation for chronic limb threatening ischaemiaHTG637
Avalglucosidase alfa for treating Pompe diseaseTA821
Ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infectionsAMR1
Cefiderocol for treating severe drug-resistant gram-negative bacterial infectionsAMR2
Nivolumab with ipilimumab for untreated unresectable malignant pleural mesotheliomaTA818
Sacituzumab govitecan for treating unresectable triple-negative advanced breast cancer after 2 or more therapiesTA819
Type 1 diabetes in adults: diagnosis and managementNG17
SecurAcath for securing percutaneous cathetersHTG440
Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDsTA815
Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancerTA816
Nivolumab for adjuvant treatment of invasive urothelial cancer at high risk of recurrenceTA817
Aortic remodelling hybrid stent insertion during surgical repair of an acute type A aortic dissectionHTG634

Results per page

  1. 10
  2. 25
  3. 50
  4. All